GT Biopharma, Inc., a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary natural killer cell engager, TriKE platform, announced Dr. Jeffrey Miller’s mini-oral presentation at the European Society for Medical Oncology Congress 2021.
September 20, 2021
· 7 min read